Geneus - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $98,738.45 -0.16%
Ethereum $3,347.92 -0.56%
BNB $648.97 +2.97%
Optimism $2.20 +7.32%
Arbitrum $0.82 +5.09%
Solana $259.61 +0.03%
Polygon $0.54 +16.79%
Cosmos $7.91 +19.50%
Avalanche $43.79 +21.04%

Bitcoin $98,738.45 -0.16%
Ethereum $3,347.92 -0.56%
BNB $648.97 +2.97%
Optimism $2.20 +7.32%
Arbitrum $0.82 +5.09%
Solana $259.61 +0.03%
Polygon $0.54 +16.79%
Cosmos $7.91 +19.50%
Avalanche $43.79 +21.04%

Geneus

company

Summary
Funding Rounds
Investors

About

Geneus is a developer of gene sequencers and reagents.

51 - 100

Highlights

Details

Last Funding Type: Series B
Industries: Biotechnology
Founded date: Apr 1, 2017
Number Of Employee: 51 - 100
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

—

Geneus has raised a total of — in funding over 2 rounds. Their latest funding was raised on Sep 28, 2021 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 28, 2021	Series B	—	2	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

2

Geneus is funded by 2 investors. Darun Touzi and Rays Venture Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Darun Touzi	—	Series B
Rays Venture Capital	—	Series B